SCHEMBL6709977

SCHEMBL6709977

Cn1c(C(=O)Nc2ccc(Cl)cc2-c2nnn[nH]2)cc2cccc(OCCCOc3ccccc3)c21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 1/20 0.36
MAPT P10636 2/20 0.35
LMNA P02545 1/20 0.35
BCL2L1 Q07817 1/20 0.35
MCL1 Q07820 1/20 0.35
BAD Q92934 1/20 0.35
CHRM3 P20309 3/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
POLB P06746 1/20 0.34
G6PD P11413 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ROCK1 Q13464 1/20 0.34
AGER Q15109 1/20 0.34
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6708785 0.91 HIF1A (0.38) MAPTLMNAKMT2AAGERNPC1
SCHEMBL6711705 0.91 MAPT (0.36) GRM4MAPTLMNAMEN1KMT2A
SCHEMBL6707977 0.91 IRAK4 (0.37) GRM4MAPTLMNAMEN1KMT2A
SCHEMBL6710432 0.90 LMNA (0.35) MAPTLMNACHRM3MEN1KMT2A
SCHEMBL6707711 0.89 MAPT (0.39) GRM4MAPTLMNAPOLBG6PD
SCHEMBL6710193 0.89 PPARG (0.36) GRM4MAPTLMNABCL2L1MCL1
SCHEMBL6710394 0.85 KDM1A (0.37) GRM4MAPTLMNACHRM3KDM1A
SCHEMBL6710050 0.85 TSHR (0.38) GRM4MAPTLMNAMEN1KMT2A
SCHEMBL6710184 0.85 GRIK1 (0.38) GRM4MAPTLMNACHRM3POLB
SCHEMBL6710121 0.85 IRAK4 (0.39) GRM4MAPTLMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GRM4 4668/4885MAPT 4754/4885LMNA 4062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.